FILTER

LATEST INTERVIEWS

Mike Campigotto

PRESIDENT, SAFESIGHT EXPLORATION
SafeSight Exploration explains how using its’ Drones, LiDAR and imaging technology can increase efficiencies and safety in the mine.

Keith Crandell

CO-FOUNDER & MANAGING DIRECTOR, ARCH VENTURE PARTNERS
ARCH Venture Partners explains the secrets to successful innovation in todays’ life sciences.

Daniel J. O’Connor

PRESIDENT & CEO, ONCOSEC MEDICAL INCORPORATED
OnoSec Medical explains how treating cancers with a plasmid-based approach can avoid side effects and work on immunologically cold tumors.

Jorge Nogueira

CEO, DIPHARMA FRANCIS
Dipharma speaks to GBR of how it is adapting to market trends and expanding its geography.

Kenneth Lim

GENERAL MANAGER AND SITE DIRECTOR, NESTE SINGAPORE
Neste explains how it is expanding its renewable solutions’ production capacity in Singapore and its innovations in recycling waste.

Steve Botts

PRESIDENT, SANTA BARBARA CONSULTANTS
With growing concern over environmental, health and safety issues, Santa Barbara explains how it can assist miners in Peru.

Peter Meath

CO-HEAD OF HEALTHCARE AND LIFE SCIENCES, MIDDLE MARKET, J.P. MORGAN COMMERCIAL BANKING
"While the underlying business model for life sciences companies hasn’t changed as a result of our current environment, we’re seeing that increased capital has been made available to those seeking funding. This makes it an incredibly promising time for the sector."

Timothy J. Miller

PRESIDENT & CEO, FORGE BIOLOGICS
"What we are seeing is a reflection of the power of genetic medicine, where the technology has demonstrated clinical promise, as well as safety. Now, in many aspects, it is up to the manufacturing to catch up as that demand for gene therapy manufacturers far exceeds the capacity."

Lesley Millar-Nicholson

DIRECTOR, MIT TECHNOLOGY LICENSING OFFICE
"MIT spins out over 32 startup companies per year approximately, and we have about 358 companies that are still alive, so the ecosystem is functioning well."

Enrique Sattler

CEO, ROBOCON
Robocon speaks with GBR about the outlook for its services in Peru.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS